Biostax Corp (BTAX)

[noreen]

Why it didn't go to the next phase in the trials? What do you mean exactly? I'm looking at Page 8 of the presentation you linked, and it does give dates of what "is next". It says they anticipate getting regulatory approval for LDN with Chrohn's disease in Q4 of 2018. This is Cytocom, again which IMUN owns a 55% stake in. The company is basically low on money and can't really do things any faster than they are already doing them from my understanding. Cytocom's primary focus is getting regulatory approval for LDN for Crohn's disease. I believe that Crohn's disease will eventually be their biggest revenue stream which is why they are focusing on that first.